Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clinton F Stewart

Showing results (171-180 of 220) with videos related to

Pageof 22
Sort By:
British Journal of Clinical Pharmacology|October 29, 2019
Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumoursJohn C Panetta, Jessica K Roberts, Jie Huang, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2010
A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomasJ Russell Geyer, Clinton F Stewart, Mehmet Kocak, et al.
Investigative Ophthalmology & Visual Science|March 20, 2012
Intra-ophthalmic artery chemotherapy triggers vascular toxicity through endothelial cell inflammation and leukostasisJena J Steinle, Qiuhua Zhang, Karin Emmons Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumorsWayne L Furman, Kristine R Crews, Catherine Billups, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2014
Population pharmacokinetics of bevacizumab in children with osteosarcoma: implications for dosingDavid C Turner, Fariba Navid, Najat C Daw, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 16, 2010
Whole-body physiologically based pharmacokinetic model for nutlin-3a in mice after intravenous and oral administrationFan Zhang, Michael Tagen, Stacy Throm, et al.
Neuro-Oncology Advances|January 7, 2022
Phase I study using crenolanib to target PDGFR kinase in children and young adults with newly diagnosed DIPG or recurrent high-grade glioma, including DIPGChristopher L Tinkle, Alberto Broniscer, Jason Chiang, et al.
Cancer Letters|November 6, 2018
Combinatorial screening using orthotopic patient derived xenograft-expanded early phase cultures of osteosarcoma identify novel therapeutic drug combinationsAmos H P Loh, Elizabeth Stewart, Cori L Bradley, et al.
Journal of Neuro-Oncology|November 20, 2014
Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC studyRoger J Packer, Brian R Rood, David C Turner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2013
Phase I trial, pharmacokinetics, and pharmacodynamics of vandetanib and dasatinib in children with newly diagnosed diffuse intrinsic pontine gliomaAlberto Broniscer, Sharyn D Baker, Cynthia Wetmore, et al.
Pageof 22

Showing results (171-180 of 220) with videos related to

Sort By:
Pageof 22
British Journal of Clinical Pharmacology|October 29, 2019
Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumoursJohn C Panetta, Jessica K Roberts, Jie Huang, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 2010
A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomasJ Russell Geyer, Clinton F Stewart, Mehmet Kocak, et al.
Investigative Ophthalmology & Visual Science|March 20, 2012
Intra-ophthalmic artery chemotherapy triggers vascular toxicity through endothelial cell inflammation and leukostasisJena J Steinle, Qiuhua Zhang, Karin Emmons Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumorsWayne L Furman, Kristine R Crews, Catherine Billups, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2014
Population pharmacokinetics of bevacizumab in children with osteosarcoma: implications for dosingDavid C Turner, Fariba Navid, Najat C Daw, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 16, 2010
Whole-body physiologically based pharmacokinetic model for nutlin-3a in mice after intravenous and oral administrationFan Zhang, Michael Tagen, Stacy Throm, et al.
Neuro-Oncology Advances|January 7, 2022
Phase I study using crenolanib to target PDGFR kinase in children and young adults with newly diagnosed DIPG or recurrent high-grade glioma, including DIPGChristopher L Tinkle, Alberto Broniscer, Jason Chiang, et al.
Cancer Letters|November 6, 2018
Combinatorial screening using orthotopic patient derived xenograft-expanded early phase cultures of osteosarcoma identify novel therapeutic drug combinationsAmos H P Loh, Elizabeth Stewart, Cori L Bradley, et al.
Journal of Neuro-Oncology|November 20, 2014
Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC studyRoger J Packer, Brian R Rood, David C Turner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2013
Phase I trial, pharmacokinetics, and pharmacodynamics of vandetanib and dasatinib in children with newly diagnosed diffuse intrinsic pontine gliomaAlberto Broniscer, Sharyn D Baker, Cynthia Wetmore, et al.
Pageof 22